THE FIRST EXPERIENCE OF TELBIVUDINE THERAPY IN LIVER TRANSPLANT PATIENTS

THE FIRST EXPERIENCE OF TELBIVUDINE THERAPY IN LIVER TRANSPLANT PATIENTS

The first Russian experience of using telbivudine in liver transplant patients discussed in this article. Goal of telbivudine therapy in patients after liver transplantation was a prophylaxis and treatment of chronic hepatitis B recurrence. First data were received after 12 months since start of the...

Full description

Bibliographic Details
Main Authors:	O. A. Gerasimova, D. A. Granov, F. K. Zherebtsov, V. V. Borovik
Format:	Article
Language:	Russian
Published:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2010-06-01
Series:	Вестник трансплантологии и искусственных органов
Subjects:	liver transplantation chronic hepatitis b telbivudine
Online Access:	https://journal.transpl.ru/vtio/article/view/287

Similar Items

Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation
by: Li-fen Han, et al.
Published: (2019-07-01)

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
by: Eun Hye Kim, et al.
Published: (2013-03-01)

Growth and development of children prenatally exposed to telbivudine administered for the treatment of chronic hepatitis B in their mothers
by: Huihui Zeng, et al.
Published: (2015-04-01)

Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections
by: Weiqiang Gan, et al.
Published: (2020-12-01)

Comparison of Renal Safety of Tenofovir and Telbivudine in Chronic Hepatitis B Patients: A Real World Study in Indonesia
by: Rino Alvani Gani
Published: (2018-09-01)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
by: Debraj Malakar, et al.
Published: (2021-01-01)

Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up
by: Wei Yi, et al.
Published: (2021-12-01)

The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis
by: Deng Min, et al.
Published: (2012-09-01)

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure
by: Abul H Manik, et al.
Published: (2021-01-01)

Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature
by: Jinxin Zheng, et al.
Published: (2017-11-01)

Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
by: Yandi Li, et al.
Published: (2022-01-01)

Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
by: Weihui Sun, et al.
Published: (2017-04-01)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
by: Teerha Piratvisuth, et al.
Published: (2016-04-01)

COMPARATIVE RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH VIRAL CIRRHOSIS AND AUTOIMMUNE LIVER DISEASES AT A SINGLE CENTER
by: O.A Gerasimova, et al.
Published: (2012-03-01)

Extrahepatic malignant neoplasms after liver transplantation: the experience of a single transplant center
by: O. A. Gerasimova, et al.
Published: (2020-02-01)

Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
Published: (2015-11-01)

DFT/TDDFT calculations of geometry optimization, electronic structure and spectral properties of clevudine and telbivudine for treatment of chronic hepatitis B
by: Dereje Fedasa Tegegn, et al.
Published: (2024-04-01)

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B
by: Yue Ying, et al.
Published: (2018-04-01)

LIVER TRANSPLANTATION IN HEPATITIS DELTA: SOUTH AMERICA EXPERIENCE
by: Daniel Souza LIMA, et al.

Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: A head-to-head study
by: Shu Yu, et al.
Published: (2014-01-01)

On indications for repeat liver transplantation
by: V. V. Borovik, et al.
Published: (2023-04-01)

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells
by: Thomas Zobel, et al.
Published: (2019-03-01)

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
by: Wenjun Wang, et al.
Published: (2016-03-01)

COMPARATIVE STUDY OF EMOTIONAL DISORDERS STRUCTURE IN PATIENTS BEFORE AND AFTER ORTHOTOPIC LIVER TRANSPLANTATION
by: T. G. Mikhaylichenko, et al.
Published: (2011-06-01)

Everolimus in clinical practice after liver transplantation: a single-center experience
by: O. A. Gerasimova, et al.
Published: (2017-06-01)

Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy
by: Jin Shang, et al.
Published: (2021-04-01)

Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients
by: Ching-Chung Lin, et al.
Published: (2016-01-01)

REPEATED LIVER TRANSPLANTATION: EXPERIENCE OF RUSSIAN SCIENTIFIC CENTER OF RADIOLOGY AND SURGICAL TECHNOLOGY (RSCRST)
by: D. A. Granov, et al.
Published: (2011-12-01)

LIVER TRANSPLANTATION. A SINGLE CENTER EXPERIENCE OF 100 CASES
by: A. M. Granov, et al.
Published: (2012-12-01)

Eficácia do adefovir dipivoxil, entecavir e telbivudina para o tratamento da hepatite crônica B: revisão sistemática The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review
by: Alessandra Maciel Almeida, et al.
Published: (2010-08-01)

Transjugular intrahepatic portocaval shunting as a preparation phase for liver transplantation
by: P. G. Tarazov, et al.
Published: (2018-08-01)

FEATURES OF SUBPOPULATION COMPOSITION OF BLOOD LYMPHOCYTES IN RECIPIENTS WITHIN THE FIRST MONTH AFTER LIVER TRANSPLANTATION
by: A. N. Shoutko, et al.
Published: (2015-04-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B
by: Claudia Alves COUTO, et al.
Published: (2001-12-01)

POSTOPERATIVE VENTRAL HERNIA IN PATIENTS, WHO UNDERGONE THE LIVER TRANSPLANTATION OPERATION
by: V. V. Borovik, et al.
Published: (2018-01-01)

Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient
by: Ralf Bahde, et al.
Published: (2011-07-01)

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort studyResearch in context
by: Peng Li, et al.
Published: (2023-03-01)

Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B
by: Jun Ge, et al.
Published: (2017-09-01)

Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
by: V. V. Borovik, et al.
Published: (2022-09-01)

Liver transplantation
by: Asemi, S
Published: (1995-04-01)